Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ilaria Montali

Showing results (11-20 of 15) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 15 results.
Gut|September 1, 2025
Immunosuppressive contribution of tumour-infiltrating B cells in human intrahepatic cholangiocarcinoma and their role in chemoimmunotherapy outcomeGiulia Milardi, Barbara Franceschini, Chiara Camisaschi, et al.
Gut|January 30, 2023
Phenotypic CD8 T cell profiling in chronic hepatitis B to predict HBV-specific CD8 T cell susceptibility to functional restoration in vitroMarzia Rossi, Andrea Vecchi, Camilla Tiezzi, et al.
Iscience|June 5, 2023
Natural heteroclitic-like peptides are generated by SARS-CoV-2 mutationsCamilla Tiezzi, Andrea Vecchi, Marzia Rossi, et al.
Gut|July 20, 2024
HBcrAg values may predict virological and immunological responses to pegIFN-α in NUC-suppressed HBeAg-negative chronic hepatitis BAndrea Vecchi, Marzia Rossi, Camilla Tiezzi, et al.
Cell|June 19, 2024
Therapeutic potential of co-signaling receptor modulation in hepatitis BFrancesco Andreata, Chiara Laura, Micol Ravà, et al.
Pageof 2

Showing results (11-20 of 15) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 15 results.
Gut|September 1, 2025
Immunosuppressive contribution of tumour-infiltrating B cells in human intrahepatic cholangiocarcinoma and their role in chemoimmunotherapy outcomeGiulia Milardi, Barbara Franceschini, Chiara Camisaschi, et al.
Gut|January 30, 2023
Phenotypic CD8 T cell profiling in chronic hepatitis B to predict HBV-specific CD8 T cell susceptibility to functional restoration in vitroMarzia Rossi, Andrea Vecchi, Camilla Tiezzi, et al.
Iscience|June 5, 2023
Natural heteroclitic-like peptides are generated by SARS-CoV-2 mutationsCamilla Tiezzi, Andrea Vecchi, Marzia Rossi, et al.
Gut|July 20, 2024
HBcrAg values may predict virological and immunological responses to pegIFN-α in NUC-suppressed HBeAg-negative chronic hepatitis BAndrea Vecchi, Marzia Rossi, Camilla Tiezzi, et al.
Cell|June 19, 2024
Therapeutic potential of co-signaling receptor modulation in hepatitis BFrancesco Andreata, Chiara Laura, Micol Ravà, et al.
Pageof 2